The Lancet. Infectious diseases
Targeting the SARS-CoV-2 reservoir in long COVID.
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
Plasma-based antigen persistence in the post-acute phase of COVID-19.
The emergence of artemisinin partial resistance in Africa: how do we respond?
Post-viral sequelae of COVID-19 and influenza.
Improving measurement of tuberculosis care cascades to enhance people-centred care.
A partner protection package for HIV cure-related trials involving analytical treatment interruptions.
Advancing detection and response capacities for emerging and re-emerging pathogens in Africa.
New boosters are here! Who should receive them and when?
Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study.
